» Articles » PMID: 33391943

Racial Disparities in Malignant Primary Brain Tumor Survival in Texas From 1995 to 2013

Overview
Journal Cureus
Date 2021 Jan 4
PMID 33391943
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Differences among the top five races in Texas will be explored to determine if racial, geographic, and healthcare disparities exist in patients undergoing treatment for a primary malignant brain tumor.

Methods: Data were obtained from the Texas Cancer Registry from 1995 to 2013. SAS 9.3 (SAS Institute, Inc., Cary, NC) and SEER*Stat 8.3.2 (National Cancer Institute, Bethesda, MD) software were used to analyze death from malignant brain tumors and cause-specific survival. Survival rates were compared using Kaplan-Meier curves and Log-Rank tests. Hazard ratios were estimated using the Cox proportional hazards regression model.

Results: Median survival was highest among Asians at 92 months (95% CI: 72, 142) and least among Whites at 20 months (95% CI: 19, 21). Patients living in the Upper Gulf Coast region of Texas had the longest survival time at 31 months (95% CI 29-35%), while those patients in the Texas Panhandle had the shortest survival time at 18 months (95% CI 14-23%). Patients with a poverty index of 0-5% had the highest median survival time of 32 months (95% CI 29-35%), as compared to patients with a poverty index of 10-20% who had a median survival of 22 months (95% CI 21-24%).

Conclusions: Ethnic minorities and higher socioeconomic class demonstrated survival advantage. White males had the worst survival of those with primary malignant brain tumors. Other significant factors affecting a patient's survival rate included geographic location, poverty index, sex, and age, thus suggesting a potential genetic and environmental influence.

Citing Articles

The impact of socioeconomic determinants on the access to care and survival in patients with spinal chordomas- a national cancer database analysis.

Battistin U, Nguyen R, Ghaith A, El-Hajj V, Soltan F, Ghaith S J Neurooncol. 2024; 169(2):359-368.

PMID: 39102119 DOI: 10.1007/s11060-024-04745-9.


Artificial intelligence in neuro-oncology: advances and challenges in brain tumor diagnosis, prognosis, and precision treatment.

Khalighi S, Reddy K, Midya A, Pandav K, Madabhushi A, Abedalthagafi M NPJ Precis Oncol. 2024; 8(1):80.

PMID: 38553633 PMC: 10980741. DOI: 10.1038/s41698-024-00575-0.


Survival Analysis of Demographic Factors Associated With 5+ Year Survival of Pancreatic Carcinoma.

Anama-Green C, Quinn M Cureus. 2021; 13(1):e13032.

PMID: 33665053 PMC: 7924966. DOI: 10.7759/cureus.13032.

References
1.
Malmer B, Henriksson R, Gronberg H . Familial brain tumours-genetics or environment? A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain tumour patients. Int J Cancer. 2003; 106(2):260-3. DOI: 10.1002/ijc.11213. View

2.
Dunwoodie L, Poehlman W, Ficklin S, Feltus F . Discovery and validation of a glioblastoma co-expressed gene module. Oncotarget. 2018; 9(13):10995-11008. PMC: 5834250. DOI: 10.18632/oncotarget.24228. View

3.
Sun T, Warrington N, Rubin J . Why does Jack, and not Jill, break his crown? Sex disparity in brain tumors. Biol Sex Differ. 2012; 3:3. PMC: 3293746. DOI: 10.1186/2042-6410-3-3. View

4.
Ambe S, Lyon K, Nizamutdinov D, Fonkem E . Incidence trends, rates, and ethnic variations of primary CNS tumors in Texas from 1995 to 2013. Neurooncol Pract. 2018; 5(3):154-160. PMC: 6075522. DOI: 10.1093/nop/npx030. View

5.
Kasl R, Brinson P, Chambless L . Socioeconomic status does not affect prognosis in patients with glioblastoma multiforme. Surg Neurol Int. 2016; 7(Suppl 11):S282-90. PMC: 4866060. DOI: 10.4103/2152-7806.181985. View